Search
for
Sort by
Research 601–630 of 1000+
- Interleukin-10-deficient Mice Are Less Susceptible to the Induction of Alopecia Areata
- Biomarkers in alopecia Areata: A systematic review and meta-analysis.
- Alopecia Areata: An Updated Review for 2023
- Immune therapies for alopecia areata: evidence and new perspectives
- Intralesional methotrexate in patchy alopecia areata: trichoscopic evaluation and effect on lesional tumour necrosis factor alpha
- Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata
- A phase 2a trial of brepocitinib for cicatricial alopecia
- A bibliometric analysis of T cell and atherosclerosis
- Serum level of vitamin D in patients with alopecia areata
- Serum interleukin-37 and its gene polymorphism (rs3811047) in Egyptian patients with alopecia areata
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Osteopontin: a new facilitating factor in alopecia areata pathogenesis?
- 51223 A novel human disease model of alopecia areata to evaluate benefit of the DHODH inhibitor farudodstat
- Epidermal Vascular Endothelial Growth Factor Production Is Required for Permeability Barrier Homeostasis, Dermal Angiogenesis, and the Development of Epidermal Hyperplasia
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Tissue Regeneration: Hair Follicle as a Model
- The expanding impact of T-regs in the skin
- Folate receptor β performs an immune checkpoint function in activated macrophages
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Laser Capture Microdissection Reveals Transcriptional Abnormalities in Alopecia Areata before, during, and after Active Hair Loss
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes